Answers are grounded in this paper and cite their sources.
Evaluates rapid neutralizing antibody quantification in influenza virus detection, suggesting improved public health responses.
Summary The focus reduction assay (FRA) is a widely used method in influenza virus research and surveillance to evaluate neutralizing antibodies. However, traditional FRA relies on time-consuming, labor-intensive immunostaining workflows that constrain throughput. Here, we used a fluorogenic neuraminidase (NA) substrate, BTP3-Neu5Ac, to directly visualize viral foci without immunostaining. Foci were captured with a fluorescence plate reader, and neutralizing antibody titers were determined from foci counts across antibody dilutions. This assay, termed DirectView-FRA, was applied to measure the neutralizing activity of antisera and monoclonal antibodies against seasonal A(H1N1)pdm09, A(H3N2), B/Victoria, and B/Yamagata viruses, as well as high pathogenicity avian influenza A(H5N1) viruses. Results were consistent with those of the traditional FRA. By simplifying the workflow, DirectView-FRA enables rapid, high-throughput testing of neutralizing antibodies to support timely public health responses during influenza epidemics and to assess viruses with pandemic potential.
No takes yet. Share an insight, caveat, or question.
Feng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: